Peter Goldschmidt

Alvotech and STADA Pave Way resolve European Patent Dispute With AbbVie and launch UKYNDRA®(AVT02)

April 6, 202212 min read

REYKJAVIK, Iceland & BAD VILBEL, Germany, 06.04.2022 – Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines

Tag: Peter Goldschmidt

Alvotech and STADA Pave Way resolve European Patent Dispute With AbbVie and launch UKYNDRA®(AVT02)

You May Have Missed

The Vodia PBX Now Supports Grok

ePostcode Highlights Address Validation Support for UK Delivery and Logistics Operations

WLS Reports Rapid Growth in Automatic Driveway Gate Installations Across London and the South East

LBV Fashion Shares Expert Tips on Choosing the Right Jacket for Petite Frames